Related references
Note: Only part of the references are listed.Turning up the heat on non-immunoreactive tumors: pyroptosis influences the tumor immune microenvironment in bladder cancer
Xingyu Chen et al.
ONCOGENE (2021)
100 years of Bacillus Calmette-Guerin immunotherapy: from cattle to COVID-19
Niyati Lobo et al.
NATURE REVIEWS UROLOGY (2021)
Advances in bladder cancer biology and therapy
Linda Tran et al.
NATURE REVIEWS CANCER (2021)
Pyroptosis: A new frontier in cancer
Yuan Fang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
AIM2 inflammasome surveillance of DNA damage shapes neurodevelopment
Catherine R. Lammert et al.
NATURE (2020)
AIM2 in health and disease: Inflammasome and beyond
Puja Kumari et al.
IMMUNOLOGICAL REVIEWS (2020)
Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect
Jiansong Han et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Immunobiology and structural biology of AIM2 inflammasome
Bing Wang et al.
MOLECULAR ASPECTS OF MEDICINE (2020)
Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling
Anthony C. Antonelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The Cost to Medicare of Bladder Cancer Care
Frank A. Sloan et al.
EUROPEAN UROLOGY ONCOLOGY (2020)
Inflammatory cytokines in bladder cancer
Pejman Shadpour et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
A surgical orthotopic approach for studying the invasive progression of human bladder cancer
Guadalupe Lorenzatti Hiles et al.
NATURE PROTOCOLS (2019)
Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment
Lingman Ma et al.
CELL DEATH & DISEASE (2019)
AIM2 promotes non-small-cell lung cancer cell growth through inflammasome-dependent pathway
Minda Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
Role of AIM2 inflammasome in inflammatory diseases, cancer and infection
Bhesh Raj Sharma et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
The role of pyroptosis in cancer: pro-cancer or pro-host?
Xiaojing Xia et al.
CELL DEATH & DISEASE (2019)
Mechanisms of BCG immunotherapy and its outlook for bladder cancer
Caroline Pettenati et al.
NATURE REVIEWS UROLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
White paper on microbial anti-cancer therapy and prevention
Neil S. Forbes et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis
Shi-Lu Chen et al.
MOLECULAR ONCOLOGY (2017)
Bladder cancer
Oner Sanli et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
'Hints' in the killer protein gasdermin D: unveiling the secrets of gasdermins driving cell death
Shiqiao Qiu et al.
CELL DEATH AND DIFFERENTIATION (2017)
Pyroptosis is involved in the pathogenesis of human hepatocellular carcinoma
Qun Chu et al.
ONCOTARGET (2016)
Inflammasomes: mechanism of assembly, regulation and signalling
Petr Broz et al.
NATURE REVIEWS IMMUNOLOGY (2016)
The NLRP1 Inflammasome Attenuates Colitis and Colitis-Associated Tumorigenesis
Tere M. Williams et al.
JOURNAL OF IMMUNOLOGY (2015)
Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt
Justin E. Wilson et al.
NATURE MEDICINE (2015)
Differential expression of inflammasomes in lung cancer cell lines and tissues
Hui Kong et al.
TUMOR BIOLOGY (2015)
Inflammasomes in cancer: a double-edged sword
Ryan Kolb et al.
PROTEIN & CELL (2014)
Synthetic Oligodeoxynucleotides Containing Suppressive TTAGGG Motifs Inhibit AIM2 Inflammasome Activation
John J. Kaminski et al.
JOURNAL OF IMMUNOLOGY (2013)
TRIF Licenses Caspase-11-Dependent NLRP3 Inflammasome Activation by Gram-Negative Bacteria
Vijay A. K. Rathinam et al.
CELL (2012)
Tumour inflammasome-derived IL-1ß recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma
Lih-Chyang Chen et al.
EMBO MOLECULAR MEDICINE (2012)
Mouse Bladder Wall Injection
Chi-Ling Fu et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
Irving C. Allen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses
Vijay A. K. Rathinam et al.
NATURE IMMUNOLOGY (2010)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)